GET DAILY SIGNALSWhy Is AMN Healthcare Services (AMN) Stock Down -22.71% Today?
Key Takeaways
- AMN shares plunged roughly 22.7% on Thursday, sliding from a prior close of $47.42 to about $36.65.
- The sell-off followed a third-quarter earnings beat that investors judged to be "low quality," driven heavily by a one-time labor-disruption reserve release.
- Guidance disappointed: fourth-quarter revenue is expected to decline 10–12% year over year as high-margin labor-disruption revenue fades.
- Margin guidance also weakened sharply, with fourth-quarter operating margin projected near breakeven versus 7% in the third quarter.
- The stock had more than tripled over the past year, leaving it vulnerable to profit-taking as it traded well above the average analyst price target.
- Traders are now watching whether core travel-nurse and allied demand can offset fading strike-related revenue in 2027.
- For more detail on valuation, visit Price Targets, Earnings, and Forecast pages.
- Explore Trending AI Robots to see which automated strategies are currently leading the market.
Opening Summary
AMN Healthcare Services, Inc. (NYSE: AMN) is a leading provider of technology-enabled healthcare workforce solutions and staffing services, operating across nurse and allied, physician and leadership, and technology and workforce solutions segments. Shares of the healthcare staffing company tumbled on Thursday, falling roughly 22.71% to around $36.65 from a previous session close of $47.42. The market reaction came despite a headline third-quarter earnings beat, as investors focused instead on a sharp pullback in forward guidance and the one-time nature of much of the quarter's outperformance.
Earnings Beat Masked by a Low-Quality Upside
AMN reported third-quarter adjusted EPS of $1.16, far exceeding the roughly $0.23 consensus estimate, while revenue of $717.3 million topped forecasts of about $649 million. However, a substantial portion of that upside was driven by a $51 million favorable reserve adjustment tied to prior labor-disruption events, which lifted both revenue and gross margin. Excluding strike-related activity, the underlying growth picture was more modest, and investors appeared unwilling to reward results that were flattered by non-recurring items.
Weak Fourth-Quarter Guidance Weighed on Sentiment
The primary catalyst for the decline was forward guidance. Management projected fourth-quarter revenue of $655 million to $670 million, implying a 10–12% year-over-year decline as labor-disruption revenue shrinks to about $5 million from $124 million a year earlier. Profitability guidance also deteriorated, with gross margin guided to 25.7%–26.2% versus 31.9% in the third quarter and operating margin expected to be roughly breakeven. The earnings-driven move reflected concern that the company's most profitable revenue stream is fading just as core demand dynamics remain competitive.
International Nurse Headwinds and Segment Softness
Additional bearish catalysts reinforced the sell-off. Management flagged that ongoing embassy visa appointment delays will constrain international nurse placements into 2027. Meanwhile, the Technology and Workforce Solutions segment saw revenue fall 9% year over year on continued pricing pressure in language services, and the Physician and Leadership Solutions segment slipped 4%. Together, these factors tempered enthusiasm around the strong travel-nurse and allied volume growth, which rose 21% and 12%, respectively.
Market Context and Trading Activity
The decline reflected a profit-taking dynamic as much as a fundamental reset. AMN shares had surged more than 140% over the prior 52 weeks and were trading well above the average analyst price target near $36.57, leaving the stock vulnerable to a sharp correction on any perceived disappointment. Trading volume was elevated relative to recent sessions as investors digested the results. The move appeared idiosyncratic to AMN rather than a broad healthcare-sector rotation, with the post-earnings slide reflecting stock-specific guidance concerns.
What Comes Next for AMN
Looking ahead, investors will focus on whether core travel-nurse and allied demand can sustain momentum and offset the disappearing labor-disruption revenue. Key watch items include bill-rate trends, international visa appointment normalization, the outcome of the company's competitive Kaiser contract RFP, and progress toward a return to growth in the locum tenens and technology segments. Risks include continued margin compression, competitive pricing pressure, and execution risk in the company's multi-year growth initiatives, while upside could emerge if pricing firms and international placements recover faster than expected.
Trending AI Robots
Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in the curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing traders to align automated approaches with their own objectives. Explore the page to see which strategies are currently leading the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Aroon Indicator for AMN shows an upward move is likely
AMN's Aroon Indicator triggered a bullish signal on November 05, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 165 similar instances where the Aroon Indicator showed a similar pattern. In 136 of the 165 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMN advanced for three days, in 222 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The 10-day RSI Indicator for AMN moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 20 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 65 cases where AMN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
AMN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.478) is normal, around the industry mean (203.977). P/E Ratio (17.434) is within average values for comparable stocks, (20.904). Projected Growth (PEG Ratio) (1.159) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.097) among similar stocks. P/S Ratio (0.397) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of healthcare staffing and workforce services
Industry HospitalNursingManagement
Advertisement